The impact of corneal allograft rejection on the long-term outcome of corneal transplantation

American Journal of Ophthalmology

Volumn 140, Issue 6, 2005, Pages 1112-1122

  Coster, Douglas J ^a,b   Williams, Keryn A ^a  

^a FLINDERS UNIVERSITY   (Australia)

^b FLINDERS MEDICAL CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ANTIBODY; ANTIGEN; AZATHIOPRINE; COMPLEMENTARY DNA; CYCLOSPORIN; GLUCOCORTICOID; HISTOCOMPATIBILITY ANTIGEN; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 10; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PEPTIDE; TACROLIMUS;

ACCESSORY CELL; ANTIGEN PRESENTATION; CELL ACTIVITY; CLINICAL PRACTICE; COHORT ANALYSIS; CORNEA; CORNEA TRANSPLANTATION; DISABILITY; DISEASE MARKER; GENE THERAPY; GRAFT REJECTION; GRAFT SURVIVAL; HLA SYSTEM; HUMAN; IMMUNE SYSTEM; IMMUNOSUPPRESSIVE TREATMENT; KERATITIS; LABORATORY; LIVING DONOR; LONG TERM CARE; MOLECULAR MECHANICS; OBSERVATIONAL STUDY; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; REGISTER; REVIEW; T LYMPHOCYTE ACTIVATION; TREATMENT OUTCOME; VISUAL DISORDER;

EID: 29244455283     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2005.07.024     Document Type: Article

References (49)

1. E.K. Zirm Eine erfolgreiche totale keratoplastik Archiv fr̈ Ophthalmol 64 1906 580 593
2. K.A. Williams, D. Roder, A. Esterman, S.M. Muehlberg, D.J. Coster Factors predictive of corneal graft survival report from the Australian Corneal Graft Registry Ophthalmology 99 1992 403 414
3. B. Kaplan, J. Schold, H.-U. Meier-Kriesche Overview of large database analysis in renal transplantation Am J Transplantation 3 2003 1052 1059
4. M. Claesson, W.J. Armitage, P. Fagerholm, U. Stenevi Visual outcome in corneal grafts a preliminary analysis of the Swedish Corneal Transplant Register Br J Ophthalmol 86 2002 174 180
5. P. Medawar Immunity of homologous grafted skin III. The fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye Br J Exp Pathol 29 1948 58 69
6. J.W. Streilein Ocular immune privilege the eye takes a dim but practical view of immunity and inflammation J Leukoc Biol 74 2003 179 185
7. L. Catry, J. Van den Oord, B. Foets, L. Missotten Morphologic and immunophenotypic heterogeneity of corneal dendritic cells Graefes Arch Clin Ex Ophthalmol 229 1991 182 185
8. M.J. Jager Corneal Langerhans cells and ocular immunology Reg Immunol 4 1992 186 195
9. C.F. Whitsett, R.D. Stulting The distribution of HLA antigens on human corneal tissue Invest Ophthalmol Vis Sci 25 1984 519 524
10. K.A. Williams, J.K. Ash, D.J. Coster Histocompatibility antigen and passenger cell content of normal and diseased human cornea Transplantation 39 1985 265 269
11. J.D. Salisbury, B.M. Gebhardt Blood group antigens on human corneal cells demonstrated by immunoperoxidase staining Am J Ophthalmol 91 1981 46 50
12. P.M. Stuart, T.S. Griffith, N. Usui, J. Pepose, X. Yu, T.A. Ferguson CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival J Clin Invest 99 1997 396 402
13. A. Bill The blood-aqueous barrier Trans Ophthalmol Soc U K 105 1986 149 155
14. K.A. Williams, M.A. White, J.K. Ash, D.J. Coster Leukocytes in the graft bed associated with corneal graft failure. Analysis by immunohistology and actuarial graft survival Ophthalmology 96 1989 38 44
15. J.S. Pepose, K.M. Gardner, M.S. Nestor, R.Y. Foos, T.H. Pettit Detection of HLA class I and II antigens in rejected human corneal allografts Ophthalmology 92 1985 1480 1484
16. C. Cursiefen, L. Chen, L.P. Borges VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment J Clin Invest 113 2004 1040 1050
17. M. Kuchle, N.X. Nguyen, G.O. Naumann Aqueous flare following penetrating keratoplasty and in corneal graft rejection Arch Ophthalmol 112 1994 354 358
18. S.V. Patel, D.O. Hodge, W.M. Bourne Corneal endothelium and postoperative outcomes 15 years after penetrating keratoplasty Am J Ophthalmol 139 2005 311 319
19. J.Y. Niederkorn Mechanisms of corneal graft rejection the sixth annual Thygeson Lecture Cornea 20 2001 675 679
20. D.S. Game, R.I. Lechler Pathways of allorecognition implications for transplantation tolerance Transpl Immunol 10 2002 101 108
21. F. Boisgerault, Y. Liu, N. Anosova, E. Ehrlich, M.R. Dana, G. Benichou Role of CD4+ and CD8+ T cells in allorecognition lessons from corneal transplantation J Immunol 167 2001 1891 1899
22. T. Wekerle, J. Kurtz, S. Bigenzahn, Y. Takeuchi, M. Sykes Mechanisms of transplant tolerance induction using costimulatory blockade Curr Opin Immunol 14 2002 592 600
23. P.G. McMenamin, J. Crewe, S. Morrison, P.G. Holt Immunomorphologic studies of macrophages and MHC Class II-positive dendritic cells in the iris and ciliary body of the rat, mouse, and human eye Invest Ophthalmol Vis Sci 35 1994 3234 3250
24. S. Banerjee, F.C. Figueiredo, D.L. Easty, A.D. Dick, S.M. Nicholls Development of organized conjunctival leukocyte aggregates after corneal transplantation in rats Br J Ophthalmol 87 2003 1515 1522
25. S. Yamagami, M.R. Dana The critical role of lymph nodes in corneal alloimmunization and graft rejection Invest Ophthalmol Vis Sci 42 2001 1293 1298
26. S. Camelo, A. Shanley, A.S. Voon, P.G. McMenamin The distribution of antigen in lymphoid tissues following its injection into the anterior chamber of the rat eye J Immunol 172 2004 5388 5395
27. Y. Liu, P. Hamrah, Q. Zhang, A.W. Taylor, M.R. Dana Draining lymph nodes of corneal transplant hosts exhibit evidence for donor major histocompatibility complex (MHC) class II-positive cells derived from MHC class II-negative grafts J Exp Med 195 2002 259 268
28. N.R. Barshes, S.E. Goodpastor, J.A. Goss Pharmacologic immunosuppression Front Biosci 1 2004 411 420 9
29. S. Hegde, J.Y. Niederkorn The role of cytotoxic T lymphocytes in corneal allograft rejection Invest Ophthalmol Vis Sci 41 2000 3341 3347
30. R.A. Wolfe Long-term renal allograft survival a cup both half-full and half-empty Am J Transplant 4 2004 1215 1216
31. Williams KA, Esterman AJ, Bartlett C, Holland H, Hornsby NB, Coster DJ, on behalf of all contributors to the Australian Corneal Graft Registry. How effective is penetrating corneal transplantation? Factors influencing long-term outcome in multivariate analysis. Transplantation. Forthcoming.
32. The Collaborative Corneal Transplantation Studies Research Group The collaborative corneal transplantation studies (CCTS). Effectiveness of histocompatibility matching in high-risk corneal transplantation Arch Ophthalmol 110 1992 1392 1403
33. H.M. Boisjoly, R. Tourigny, R. Bazin Risk factors of corneal graft failure Ophthalmology 100 1993 1728 1735
34. H.J. Völker-Dieben, C.C. Kok-van Alphen, Q. Lansbergen, G.G. Persijn The effect of prospective HLA-A and -B matching on corneal graft survival Acta Ophthalmol 60 1982 203 212 (Copenh)
35. R. Khaireddin, J. Wachtlin, W. Hopfenmüller, F. Hoffmann HLA-A, HLA-B, and HLA-DR matching reduces the rate of corneal allograft rejection Graefes Arch Clin Exp Ophthalmol 241 2003 1020 1028
36. A. Vail, S.M. Gore, B.A. Bradley, D.L. Easty, C.A. Rogers, W.J. Armitage Influence of donor and histocompatibility factors on corneal graft outcome Transplantation 58 1994 1210 1216
37. K.A. Hopkins, M.G. Maguire, N.E. Fink, W.B. Bias Reproducibility of HLA-A, B, and DR typing using peripheral blood samples results of retyping in the Collaborative Corneal Transplantation Studies Hum Immunol 33 1992 122 128
38. H.J. Völker-Dieben, F.H.J. Claas, G.M.T. Schreuder Beneficial effect of HLA-DR matching on the survival of corneal allografts Transplantation 70 2000 640 648
39. D. Böhringer, T. Reinhard, S. Böhringer, J. Enczmann, E. Godehard, R. Sundmacher Predicting time on the waiting list for HLA matched corneal grafts Tissue Antigens 59 2002 407 411
40. J.C. Hill Systemic cyclosporine in high-risk keratoplasty. Short- versus long-term therapy Ophthalmology 101 1994 128 133
41. R. Sundmacher, T. Reinhard, P. Heering Six years' experience with systemic cyclosporin A prophylaxis in high-risk perforating keratoplasty patients. A retrospective study Ger J Ophthalmol 1 1992 432 436
42. A.C. Poon, J.E. Forbes, J.K. Dart Systemic cyclosporin A in high-risk penetrating keratoplasties a case-control study Br J Ophthalmol 85 2001 1464 1469
43. Inoue, C. Kimura, S. Amano Long-term outcome of systemic cyclosporine treatment following penetrating keratoplasty Jpn J Ophthalmol 45 2001 378 382
44. S. Rumelt, V. Bersudsky, T. Blum-Hareuveni, U. Rehany Systemic cyclosporin A in high failure risk, repeated corneal transplantation Br J Ophthalmol 86 2002 988 992
45. M.P. Algros, R. Angonin, B. Delbosc, J.Y. Cahn, B. Kantelip Danger of systemic cyclosporine for corneal graft Cornea 21 2002 613 614
46. A.D. Dick, P. Meyer, T. James Campath-1H therapy in refractory ocular inflammatory disease Br J Ophthalmol 84 2000 107 109
47. M.A. Thiel, D.J. Coster, S.D. Standfield Penetration of engineered antibody fragments into the eye Clin Exp Immunol 128 2002 67 74
48. K.A. Williams, C.F. Jessup, D.J. Coster Gene therapy approaches to prolonging corneal allograft survival Expert Opin Biol Ther 4 2004 1059 1071
49. S. Klebe, P.J. Sykes, D.J. Coster, R. Krishnan, K.A. Williams Prolongation of sheep corneal allograft survival by transfer of the gene encoding ovine interleukin 10 Transplantation 71 2001 1214 1220